Navigation Links
American Society of Hematology awards third round of Bridge Grants
Date:3/24/2014

(WASHINGTON, March 24, 2014) The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders, today announced the names of 15 research investigators who will receive critical interim support from the Society for hematology research proposals that, despite earning high scores, could not be funded by the National Institutes of Health (NIH) amid severe funding reductions. The support will come in the form of one-year, $100,000 ASH Bridge Grants, awards intended to help bridge these talented ASH member investigators to their next NIH research grant by funding efforts to gather additional data to strengthen the resubmission of their applications.

The 15 noteworthy ASH Bridge Grant recipients announced today join 29 hematologists that have been granted funding since ASH committed $9 million in Society funds to create the program in July 2012. Among these 29 talented investigators, nearly one-third have already successfully obtained NIH funding.

These statistics, coupled with current budget uncertainty for NIH, demonstrate a clear need for such bridge funding programs. Following a decade of flat funding for the agency, in 2013 the NIH budget was slashed by more than 5 percent as part of mandated across-the-board federal spending cuts known as sequestration. While Congress restored nearly $1 billion to the NIH budget for fiscal year 2014, a welcome boost that will allow for the creation of an estimated 385 research grants, funding for U.S. biomedical research remains insufficient to address the dire need for treatments and cures for some of the most deadly blood diseases worldwide. The current federal appropriation to NIH is more than $700 million short of the agency's pre-sequestration budget, leading an alarming number of both new and more experienced hematology researchers to consider abandoning their careers, leaving precious scientific innovation at a standstill.

"Despite small signs of improvement, the current NIH funding climate is far from perfect and the impact on biomedical innovation has been devastating," said ASH President Linda J. Burns, MD, of the University of Minnesota. "While our early success rates suggest that the ASH Bridge Grant program is making an impact, it is still a temporary fix for a larger problem. Lawmakers must understand the damaging effect that unpredictable funding will have on research and patients and invest in biomedical research."

The studies supported by ASH's third round of bridge grants span the breadth of hematology. Funded projects range from exploration of new therapeutic targets for multiple myeloma and osteolytic bone disease, to the causes and cures of anemias and iron overload disorders and the connection between autoimmunity and cancer. Other funded studies include one that evaluates drug regimens for leukemias and lymphomas based on genetic factors and another that aims to refine prognostic tools for chronic lymphocytic leukemia.

The 15 ASH Bridge Grants announced today constitute the first of two rounds of grants to be awarded this year. Beyond the Society's financial commitment that will provide for approximately 30 grants to be awarded annually through 2015, additional awards will be supplemented by support from corporate and individual contributors. Generous support from individual donors as well as Amgen, Inc.; the Atlanta Convention & Visitors Bureau; Genentech USA, Inc.; GlaxoSmithKline; Millennium: The Takeda Oncology Company; Novartis Pharmaceuticals, Inc.; and Onyx Pharmaceuticals, Inc. enabled the Society to award several additional bridge grants as part of this third round.

"As biomedical researchers across specialties find that they cannot depend solely on NIH funding, we predict that alternative funding opportunities like the ASH Bridge Grants will be increasingly valuable to the progress of U.S. biomedical innovation and will help retain talented hematologists in the field during times of financial hardship," said Dr. Burns.

Visit http://www.hematology.org/bridgegrantrecipients to view the complete list of third-round ASH Bridge Grant recipients.


'/>"/>

Contact: Kaitlin Bressler
kbressler@hematology.org
202-552-4925
American Society of Hematology
Source:Eurekalert

Related biology news :

1. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
2. Common North American frog identified as carrier of deadly amphibian disease
3. UC research tests new tool to guide reintroduction of the American chestnut
4. American Society of Plant Biologists honors early career women scientists
5. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
6. Professor known for work with hunter-gatherers elected to American Academy of Arts and Sciences
7. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
8. New study published on fertility awareness among American university students
9. The American Society for Microbiology honors Ellen Jo Baron
10. Steve Fisher joins American Health IT LLC as VP of Operations
11. University of Tennessee anthropologists find American heads are getting larger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology: